Name | Recombinant Mouse sTNF RII/TNFRSF1B Protein |
---|---|
Supplier | R&D Systems |
Catalog | 426-R2 |
Category | Protein |
Prices | $349.00 |
Sizes | 50 µg |
Species Reactivities | Mouse |
Nature | Recombinant |
Source | E. coli -derived Val23-Gly258 |
Purity | >97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Bioactivity | Measured by its ability to inhibit the TNF-alpha mediated cytotoxicity in the L‑929 mouse fibroblast cells in the presence of the metabolic inhibitor actinomycin D. Matthews, N. and M.L. Neale (1987) in Lymphokines and Interferons, A Practical Approach. Clemens, M.J. et al . (eds): IRL Press. 221. The ED 50 for this effect is 1-3 µg/mL in the presence of 0.1 ng/mL of recombinant mouse TNF-alpha. |
Endotoxin | <0.01 EU per 1 μg of the protein by the LAL method. |
SwissProt/Accession | Q545P4 |
Gene | Tnfrsf1b |
Sequence | Val23 |
Supplier Page | Shop |
Keeton R, Allie N, Dambuza I, Abel B, Hsu NJ, Sebesho B, Randall P, Burger P, Fick E, Quesniaux VF, Ryffel B, Jacobs M. J Clin Invest. 2014 Apr;124(4):1537-51.
Osuchowski MF, Welch K, Siddiqui J, Remick DG. J Immunol. 2006 Aug 1;177(3):1967-74.
Osuchowski MF, Siddiqui J, Copeland S, Remick DG. J Immunol Methods. 2005 Jul;302(1-2):172-81.
Ellaban E, Bolgos G, Remick D. Cell Immunol. 2004 Sep-Oct;231(1-2):103-11. Epub 2005 Feb 26.